Discover

News & Info

Quote List Quote List

Radiopharm Theranostics(RADX.US)

Event Tracking

Feb28

Radiopharm Theranostics released FY2026 Q1 earnings on February 27 (EST), actual revenue USD 2.041 M, actual EPS USD -1.0361

04:00

Radiopharm Theranostics released FY2026 Semi-Annual earnings on February 27 (EST), actual revenue USD 4.129 M (forecast USD 332.5 K), actual EPS USD -2.0964 (forecast USD -1.5203)

04:00

Radiopharm Theranostics released FY2026 Q2 earnings on February 27, 2026 (EST) with actual revenue of USD 2.077 M and EPS of USD -1.0544

04:00

Nov16

Radiopharm Theranostics' RAD 101 Trial Reaches 50% Enrollment May Initiate Global Phase 3 Trial

22:31

Nov12

Radiopharm Theranostics Ltd. Starts Recruiting Patients for the Third Group of 177Lu-RAD204 Trial

12:04

Nov10

Radiopharm Theranostics Ltd. Outlines Clinical Development Plans and Collaborates with MD Anderson

23:33

Schedules & Filings

Schedules

Filings

Feb27

Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 2.077 M, Net Income -9.026 M, EPS -1.0544

Aug29

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 3.287 M, Net Income -6.4 M, EPS -0.8252

Feb28

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 758.12 K, Net Income -5.824 M, EPS -0.9516

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More